A pan-cancer gamma delta T cell repertoire
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
This report presents the largest collection of gamma-delta T cell receptor (γδ TCR) reads in human cancer to date, analyzing about 11,000 patient tumor samples across 33 cancer types using the TRUST4 algorithm. Despite γδ T cells being a small fraction of the T cell population, they play a key role in both innate and adaptive immunity. Our comprehensive analysis reveals their significant presence across all cancer types, specifically highlighting the diverse spectrum and clonality patterns of their γδ receptors. This research highlights the complex roles of γδ T cells in tumor tissues and their potential as prognostic biomarkers. We also demonstrate the utility of T cell receptor gamma (TRG) and delta (TRD) gene expression values from standard RNA-seq data. Ultimately, our work establishes a fundamental resource for future tumor-infiltrating γδ T cell research and may facilitate the development of novel γδ-T-cell-based therapeutic strategies. Together, we demonstrate the strong diversity and prognostic potential of γδ T cells in multiple cancer types.
Highlights
Comprehensive analysis of γδ TCRs from 11,473 tumor samples
Significant variability and overall consistency in γδ gene expression and clonotype
γδ TCR expression and diversity as prognostic biomarkers across multiple cancers
Centralized γδ TCR repertoire database for future therapeutic discovery
